home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

39,003 rows where posted_year = 2023 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 5

  • Supporting & Related Material 25,422
  • Other 10,416
  • Notice 2,115
  • Proposed Rule 537
  • Rule 513

agency_id 5

  • EPA 24,135
  • FDA 13,127
  • FWS 1,288
  • APHIS 248
  • USDA 205

posted_year 1

  • 2023 · 39,003 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
EPA_FRDOC_0001-30344 EPA EPA_FRDOC_0001 Environmental Impact Statements; Availability, etc. Notice   2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T13:38:49Z 2023-28749 0 0 0900006486365be4
EPA-HQ-OPP-2023-0597-0001 EPA EPA-HQ-OPP-2023-0597 Exemption: Clothianidin Notice   2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z 2024-01-17T04:59:59Z 2024-01-17T02:01:01Z 2023-28772 0 0 0900006486365b43
EPA-R09-OAR-2023-0599-0002 EPA EPA-R09-OAR-2023-0599 Maricopa County Rule 100 letter signed Supporting & Related Material   2023-12-29T05:00:00Z 2023 12     2023-12-30T01:55:16Z   0 0 09000064863670ec
EPA-R09-OAR-2023-0599-0003 EPA EPA-R09-OAR-2023-0599 TSD MCAQD NSR Rule 100 2023-0599 12-4-2023 Supporting & Related Material   2023-12-29T05:00:00Z 2023 12     2023-12-30T01:55:29Z   0 0 0900006486366f6a
EPA-HQ-OLEM-2020-0107-0983 EPA Hazardous and Solid Waste Management System: Disposal of Coal Combustion Residuals from Electric Utilities; Legacy Surface Impoundments EPA-HQ-OLEM-2020-0107 Memo to docket Meeting with Duke Energy November 29, 2023 with attached presentation Supporting & Related Material Meeting Materials 2023-12-29T05:00:00Z 2023 12     2023-12-30T01:32:20Z   0 0 09000064863670eb
EPA-HQ-OPP-2023-0597-0002 EPA EPA-HQ-OPP-2023-0597 FIFRA Section 18 Emergency Exemption Renewal Request For Belay Insecticide (clothianidin; 23.0%) (24FL01- Application - 20231117) Supporting & Related Material   2023-12-29T05:00:00Z 2023 12     2023-12-30T01:38:22Z   0 0 090000648634947f
EPA-R06-OAR-2022-0907-0006 EPA EPA-R06-OAR-2022-0907 AR039.06 Air Quality State Implementation Plans; Approvals and Promulgations; Arkansas; Revisions to Rule 19: Rules of the Arkansas Plan of Implementation for Air Pollution Control, Final rule, 5 pages. Rule   2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T15:30:24Z 2023-28497 0 0 0900006486365b3b
EPA-R09-OAR-2023-0449-0001 EPA EPA-R09-OAR-2023-0449 Air Quality State Implementation Plans; Approvals and Promulgations: California; San Luis Obispo County Air Pollution Control District; New Source Review Proposed Rule   2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z 2024-01-30T04:59:59Z 2023-12-29T20:05:11Z 2023-28750 0 0 0900006486365bdf
EPA-R09-OAR-2023-0599-0004 EPA EPA-R09-OAR-2023-0599 Rule100-SIP Revision Supporting & Related Material   2023-12-29T05:00:00Z 2023 12     2023-12-30T01:55:41Z   0 0 0900006486366f6b
EPA-HQ-ORD-2012-0830-0100 EPA EPA-HQ-ORD-2012-0830 Availability of the Benchmark Dose (BMD) Model Code and BMD Modeling Output Files for the Draft Integrated Risk Information System (IRIS) Toxicological Review of Inorganic Arsenic Notice   2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z 2024-01-17T04:59:59Z 2024-01-18T02:00:45Z 2023-28766 0 0 0900006486365bde
FDA-2022-E-2011-0005 FDA FDA-2022-E-2011 Letter to U. S. Patent and Trademark Office from FDA CDER Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:12:16Z   0 0 0900006486365699
FDA-2022-E-2010-0005 FDA FDA-2022-E-2010 Letter to U. S. Patent and Trademark Office from FDA CDER Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:12:02Z   0 0 0900006486365697
FDA-2022-E-2014-0005 FDA FDA-2022-E-2014 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:09:57Z   0 0 0900006486365a1a
FDA-2022-N-2226-0144 FDA FDA-2022-N-2226 Tab C - FDA Salt Substitutes - NPRM and PRIA - Final to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T17:42:15Z   0 0 0900006486366ef1
FDA-2019-N-4750-0041 FDA FDA-2019-N-4750 Memorandum to FDA DMS on Partially Hydrogenated Oils Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:56:12Z   0 0 0900006486365e65
FDA-2019-N-4750-0045 FDA FDA-2019-N-4750 Tab A - PHOs RIA - Original to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:56:30Z   0 0 0900006486365e69
FDA-1997-S-0006-2049 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 Courtesy letter and related material from FDA CFSAN to Vedistry Pvt Ltd. Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T18:04:52Z   0 0 090000648635f527
FDA-1997-S-0006-2046 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 Courtesy letter and related material from FDA CFSAN to Wooshin Industrial Co., Ltd. Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T18:04:18Z   0 0 090000648635f0c5
FDA-1997-S-0006-2043 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 Courtesy letter and related material from CFSAN to Arbonne International LLC Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T18:03:49Z   0 0 090000648635de73
FDA-1997-S-0006-2048 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 Courtesy letter and related material from FDA CFSAN to Wooshin Industrial Co., Ltd. Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T18:04:42Z   0 0 090000648635f525
FDA-2023-H-5636-0001 FDA FDA-2023-H-5636 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:34:31Z   0 0 0900006486361437
FDA-2022-E-2012-0005 FDA FDA-2022-E-2012 Letter to U. S. Patent and Trademark Office from FDA CDER Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:12:29Z   0 0 090000648636569b
FDA-2019-E-3218-0005 FDA FDA-2019-E-3218 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:03:25Z   0 0 0900006486365a16
FDA-2022-E-2013-0005 FDA FDA-2022-E-2013 Letter to U. S. Patent and Trademark Office from FDA CDER Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:12:42Z   0 0 0900006486365ce2
FDA-2019-N-4750-0048 FDA FDA-2019-N-4750 Tab B - PHOs PRIA - Comparison OMB Original to Final Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:56:55Z   0 0 0900006486365e8c
FDA-2019-N-4750-0051 FDA FDA-2019-N-4750 Tab C - PHOs NPRM - Final to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:57:23Z   0 0 0900006486365e91
FDA-2023-H-5667-0001 FDA FDA-2023-H-5667 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T16:57:02Z   0 0 0900006486365657
FDA-1997-S-0006-2044 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 Courtesy letter and related material from FDA CFSAN to CalmCo LLC Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T18:03:58Z   0 0 090000648635d608
FDA-2023-H-5657-0001 FDA FDA-2023-H-5657 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2024-01-01T05:00:00Z   2024-01-01T19:24:51Z   0 0 0900006486366f65
FDA-2023-H-5410-0001 FDA FDA-2023-H-5410 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2024-01-01T05:00:00Z   2024-01-01T18:58:41Z   0 0 0900006486365c81
FDA-2019-N-4750-0046 FDA FDA-2019-N-4750 Tab B - PHOs DFR - Comparison OMB Original to Final Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:56:46Z   0 0 0900006486365e6a
FDA-2019-N-4750-0047 FDA FDA-2019-N-4750 Tab B - PHOs NPRM - Comparison OMB Original to Final Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:56:50Z   0 0 0900006486365e6b
FDA-2019-N-4750-0050 FDA FDA-2019-N-4750 Tab C - PHOs DFR - Final to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:57:18Z   0 0 0900006486365e8e
FDA-2023-H-5663-0001 FDA FDA-2023-H-5663 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T16:52:49Z   0 0 090000648636564e
FDA-2023-H-5661-0001 FDA FDA-2023-H-5661 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T16:39:48Z   0 0 0900006486366919
FDA-2023-H-5662-0001 FDA FDA-2023-H-5662 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T16:41:58Z   0 0 090000648636692b
FDA-2022-N-2226-0142 FDA FDA-2022-N-2226 Tab A - FDA Salt Substitutes NPRM and PRIA - Original to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T17:41:54Z   0 0 0900006486366edd
FDA-2022-N-2226-0141 FDA FDA-2022-N-2226 Memorandum to FDA DMS on Salt Substitutes NPRM Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T17:41:49Z   0 0 0900006486366eda
FDA-2023-U-5565-0001 FDA FDA-2023-U-5565 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T17:07:31Z   0 0 09000064863612e4
FDA-2023-H-5665-0001 FDA FDA-2023-H-5665 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T17:15:06Z   0 0 0900006486365654
FDA-2023-H-5269-0001 FDA FDA-2023-H-5269 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T17:24:00Z   0 0 0900006486365665
FDA-1997-S-0006-2050 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 Courtesy letter and related material from FDA CFSAN to CalmCo LLC Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T18:05:03Z   0 0 090000648635f529
FDA-2019-E-5256-0005 FDA FDA-2019-E-5256 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T13:26:57Z   0 0 090000648636562d
FDA-2019-N-4750-0044 FDA FDA-2019-N-4750 Tab A - PHOs PRIA - Original to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:56:25Z   0 0 0900006486365e68
FDA-2019-N-4750-0049 FDA FDA-2019-N-4750 Tab B - PHOs RIA - Comparison OMB Original to Final Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:57:01Z   0 0 0900006486365e8d
FDA-2019-N-4750-0053 FDA FDA-2019-N-4750 Tab C - PHOs RIA - Final to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:57:32Z   0 0 0900006486365e93
FDA-2023-H-5666-0001 FDA FDA-2023-H-5666 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T16:46:57Z   0 0 0900006486364c23
FDA-2023-H-5660-0001 FDA FDA-2023-H-5660 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T16:38:09Z   0 0 09000064863665e4
FDA-2023-H-5672-0001 FDA FDA-2023-H-5672 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T17:28:45Z   0 0 0900006486365662
FDA-2019-E-3017-0005 FDA FDA-2019-E-3017 Letter to U. S. Patent and Trademark Office from FDA CDER Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:13:37Z   0 0 09000064863656c8
FDA-2022-E-2016-0005 FDA FDA-2022-E-2016 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:10:40Z   0 0 0900006486365692
FDA-2019-E-3287-0005 FDA FDA-2019-E-3287 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:14:00Z   0 0 0900006486365c60
FDA-2023-H-5673-0001 FDA FDA-2023-H-5673 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T15:05:01Z   0 0 090000648636568b
FDA-2023-H-5674-0001 FDA FDA-2023-H-5674 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T15:08:02Z   0 0 0900006486365c7b
FDA-2023-H-5603-0001 FDA FDA-2023-H-5603 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:34:53Z   0 0 0900006486365669
FDA-2019-N-4750-0052 FDA FDA-2019-N-4750 Tab C - PHOs PRIA - Final to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:57:27Z   0 0 0900006486365e92
FDA-2023-H-5177-0001 FDA FDA-2023-H-5177 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-01T05:00:00Z   2023-12-01T15:00:37Z   0 0 09000064862c07f3
FDA-2023-H-5658-0001 FDA FDA-2023-H-5658 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2024-01-02T05:00:00Z   2024-01-02T13:25:31Z   0 0 0900006486366f68
FDA-2022-N-2226-0143 FDA FDA-2022-N-2226 Tab B - FDA Salt Substitutes NPRM and PRIA - Comparison OMB Original to Final Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T17:42:10Z   0 0 0900006486366ee2
FDA-1997-S-0006-2045 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 Courtesy letter and related material from FDA CFSAN to Robinson Pharma Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T18:04:07Z   0 0 090000648635f0c2
FDA-1997-S-0006-2047 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 Courtesy letter and related material from FDA CFSAN to Wooshin Industrial Co., Ltd. Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T18:04:30Z   0 0 090000648635f521
FDA-2023-H-5664-0001 FDA FDA-2023-H-5664 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T17:02:17Z   0 0 0900006486365651
FDA-2023-H-5670-0001 FDA FDA-2023-H-5670 Complaint Other Complaint 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T16:51:21Z   0 0 0900006486366931
FDA-2019-N-4750-0042 FDA FDA-2019-N-4750 Tab A - PHOs DFR - Original to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:56:16Z   0 0 0900006486365e66
FDA-2022-E-2009-0005 FDA FDA-2022-E-2009 Letter to U. S. Patent and Trademark Office from FDA CDER Other Letter(s) 2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z   2023-12-29T14:11:49Z   0 0 0900006486365c63
FDA-2019-N-4750-0043 FDA FDA-2019-N-4750 Tab A - PHOs NPRM - Original to OMB Supporting & Related Material Background Material 2023-12-29T05:00:00Z 2023 12     2023-12-29T16:56:21Z   0 0 0900006486365e67
FWS-R8-ES-2023-0191-0001 FWS Receipt of Proposed Habitat Conservation Plan for Seven Species; Sacramento Municipal Utility District, Sacramento County, CA; Draft Environmental Assessment FWS-R8-ES-2023-0191 Draft Habitat Conservation Plan and Draft Environmental Assessment; Sacramento Municipal Utility District Operations, Maintenance, and New Construction Habitat Conservation Plan, Sacramento County, CA Notice   2023-12-29T05:00:00Z 2023 12 2023-12-29T05:00:00Z 2024-01-30T04:59:59Z 2024-01-30T02:00:37Z 2023-28719 0 0 0900006486365625
EPA-R09-OAR-2023-0203-0009 EPA EPA-R09-OAR-2023-0203 Air Quality State Implementation Plans; Approvals and Promulgations: California State Implementation Plan; San Francisco Bay Area Rule   2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T15:46:20Z 2023-28494 0 0 09000064863617e1
EPA-R09-OAR-2023-0203-0010 EPA EPA-R09-OAR-2023-0203 Final Docket Index for the Approval and Promulgation of Implementation Plans; Revisions to the CA SIP; SF Bay Area Supporting & Related Material   2023-12-28T05:00:00Z 2023 12     2023-12-29T02:07:36Z   0 0 0900006486361443
EPA-HQ-OPPT-2015-0436-0044 EPA EPA-HQ-OPPT-2015-0436 FAQs Supporting & Related Material   2023-12-28T05:00:00Z 2023 12     2023-12-29T01:38:35Z   0 0 0900006484f7a78f
EPA-R09-OAR-2023-0203-0011 EPA EPA-R09-OAR-2023-0203 E. 88 FR 89587 Approval And Promulgation of Implementation Plans; Revisions to the CA State Plan; SF Bay Area Supporting & Related Material   2023-12-28T05:00:00Z 2023 12     2023-12-29T02:07:48Z   0 0 0900006486361445
EPA-R10-OAR-2019-0647-0007 EPA EPA-R10-OAR-2019-0647 Air Quality State Implementation Plans; Approvals and Promulgations: Washington; Excess Emissions, Startup, Shutdown, and Malfunction Revisions Rule   2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T16:35:51Z 2023-28294 0 0 09000064863618c5
EPA-R02-OAR-2023-0175-0006 EPA EPA-R02-OAR-2023-0175 Air Quality State Implementation Plans; Approvals and Promulgations: New York; Emission Statement Program Rule   2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-29T19:16:51Z 2023-28343 0 0 0900006486361798
EPA-HQ-OA-2013-0320-0031 EPA Technical Guidance for Assessing Environmental Justice in Regulatory Analysis EPA-HQ-OA-2013-0320 Guidance: Assessing Environmental Justice in Regulatory Analysis Notice Extension of Comment Period 2023-12-28T05:00:00Z 2023 12     2023-12-28T15:37:42Z 2023-28598 0 0 0900006486361790
EPA-HQ-OW-2015-0680-0423 EPA EPA-HQ-OW-2015-0680 Agency Information Collection Activities; Proposals, Submissions, and Approvals: Use of Lead Free Pipes, Fittings, Fixtures, Solder and Flux for Drinking Water (Renewal) Notice   2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z 2024-01-30T04:59:59Z 2023-12-28T15:01:47Z 2023-28640 0 0 0900006486361660
EPA-HQ-OPPT-2015-0436-0043 EPA EPA-HQ-OPPT-2015-0436 Supporting Statement for OMB Review Supporting & Related Material ICR Supporting Statement 2023-12-28T05:00:00Z 2023 12     2023-12-29T01:38:47Z   0 0 0900006484f7a78e
EPA-HQ-OPPT-2023-0309-0021 EPA EPA-HQ-OPPT-2023-0309 The Asbestos Medicine Seminar November 15-17, 2023, Retrospective: The DRI Presentation of 2023, The North Carolina Asbestos Plants, Revisited: 2023 Supporting & Related Material Publication - Copyrighted Materials 2023-12-28T05:00:00Z 2023 12     2023-12-29T01:39:26Z   0 0 0900006486361325
EPA-HQ-OLEM-2023-0244-0002 EPA Hazardous and Solid Waste Management System: Disposal of Coal Combustion Residuals (CCR) EPA-HQ-OLEM-2023-0244 Agency Information Collection Activities; Proposals, Submissions, and Approvals: Disposal of Coal Combustion Residuals From Electric Utilities (Renewal) Notice   2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z 2024-01-30T04:59:59Z 2023-12-28T15:15:36Z 2023-28639 0 0 090000648636172c
EPA-R06-OAR-2023-0090-0014 EPA EPA-R06-OAR-2023-0090 OK043.13 Air Quality State Implementation Plans; Approvals and Promulgations: Oklahoma; Revisions to Air Pollution Control Rules, Final rule, first 4 pages Rule   2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T15:28:21Z 2023-28496 0 0 09000064863618c7
EPA-HQ-OPPT-2015-0436-0047 EPA EPA-HQ-OPPT-2015-0436 CDX User Guide Supporting & Related Material Publication - USEPA 2023-12-28T05:00:00Z 2023 12     2023-12-29T01:39:00Z   0 0 0900006484f7a792
EPA-HQ-OPPT-2023-0309-0020 EPA EPA-HQ-OPPT-2023-0309 Letter Peer Reviewer Comments on the White Paper: Quantitative Human Health Approach to be Applied in the Risk Evaluation for Asbestos Part 2—Supplemental Evaluation including Legacy Uses and Associated Disposals of Asbestos Supporting & Related Material Memorandum 2023-12-28T05:00:00Z 2023 12     2023-12-29T01:39:13Z   0 0 0900006486361307
EPA-HQ-OPPT-2015-0436-0045 EPA EPA-HQ-OPPT-2015-0436 Consultation - TSCA Section 4 Test Orders Website Update Supporting & Related Material   2023-12-28T05:00:00Z 2023 12     2023-12-29T01:38:22Z   0 0 0900006484f7a790
EPA-HQ-OW-2017-0300-1915 EPA EPA-HQ-OW-2017-0300 Agency Information Collection Activities; Proposals, Submissions, and Approvals: Lead and Copper Rule Revisions Notice   2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z 2024-01-30T04:59:59Z 2023-12-28T15:24:27Z 2023-28641 0 0 0900006486361915
EPA-HQ-OPPT-2015-0436-0042 EPA EPA-HQ-OPPT-2015-0436 Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Clearance for TSCA Section 4 Test Rules, Test Orders, Enforceable Consent Agreements, Voluntary Data Submissions, and Exemptions From Testing Requirements (Renewal) Notice   2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z 2024-01-30T04:59:59Z 2023-12-28T15:09:11Z 2023-28663 0 0 09000064863616e9
EPA-HQ-OPPT-2015-0436-0046 EPA EPA-HQ-OPPT-2015-0436 Emergency Request Memorandum to OMB Supporting & Related Material Memorandum 2023-12-28T05:00:00Z 2023 12     2023-12-29T01:38:09Z   0 0 0900006484f7a791
FDA-2023-H-5639-0001 FDA FDA-2023-H-5639 Complaint Other Complaint 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T15:19:51Z   0 0 090000648635d710
FDA-2023-H-5650-0001 FDA FDA-2023-H-5650 Complaint Other Complaint 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T17:50:58Z   0 0 0900006486361319
FDA-2023-D-5408-0002 FDA FDA-2023-D-5408 Reformulating Drug Products That Contain Carbomers Manufactured With Benzene; Guidance for Industry - Final Guidance Other Guidance 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2024-11-12T06:24:20Z   1 0 090000648635c332
FDA-2021-N-0039-0002 FDA FDA-2021-N-0039 Electronic Submissions; Update to the Specifications for Preparing and Submitting Postmarket Individual Case Safety Reports for Vaccines; Technical Specification Notice Notice of Availability 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2024-11-12T06:21:06Z 2023-28594 1 0 090000648636182b
FDA-2023-H-5647-0001 FDA FDA-2023-H-5647 Complaint Other Complaint 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T18:23:02Z   0 0 0900006486361407
FDA-2023-H-5648-0001 FDA FDA-2023-H-5648 Complaint Other Complaint 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T18:26:47Z   0 0 090000648636140a
FDA-2023-H-5643-0001 FDA FDA-2023-H-5643 Complaint Other Complaint 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T17:54:09Z   0 0 09000064863612e1
FDA-2023-H-5645-0001 FDA FDA-2023-H-5645 Complaint Other Complaint 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T21:03:53Z   0 0 0900006486364790
FDA-2023-D-4177-0021 FDA FDA-2023-D-4177 Quality Considerations for Topical Ophthalmic Drug Products; Revised Draft Guidance for Industry; Availability Notice Notice of Availability 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T15:10:09Z 2023-28595 0 0 090000648636165b
FDA-2023-D-4299-0002 FDA FDA-2023-D-4299 Potency Assurance for Cellular and Gene Therapy Products; Draft Guidance for Industry Other Guidance 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z 2024-03-28T03:59:59Z 2024-11-12T06:25:10Z   1 0 0900006486364261
FDA-2023-H-5637-0001 FDA FDA-2023-H-5637 Complaint Other Complaint 2023-12-28T05:00:00Z 2023 12 2024-01-01T05:00:00Z   2024-01-01T19:25:25Z   0 0 09000064863647c6
FDA-2020-Q-1295-0026 FDA FDA-2020-Q-1295 Withdrawal request for docket number FDA-2020-Q-1295 Other Withdrawal 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T18:40:58Z   0 0 0900006486364403
FDA-2020-Q-1295-0027 FDA FDA-2020-Q-1295 FDA response to a withdrawal request for CA and Migraine Final Other Acknowledgement Letter/Receipt 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T18:41:04Z   0 0 0900006486364405
FDA-2023-D-4177-0022 FDA FDA-2023-D-4177 Quality Considerations for Topical Ophthalmic Drug Products; Guidance for Industry; Draft Guidance Other Guidance 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z 2024-02-27T04:59:59Z 2025-02-04T02:01:06Z   1 0 09000064863613f7
FDA-2023-H-5644-0001 FDA FDA-2023-H-5644 Complaint Other Complaint 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T18:27:41Z   0 0 09000064863612e7

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
Powered by Datasette · Queries took 3233.516ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API